LIfT BioSciences (private company)
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth servicesManufacturing
Business model:B2B
LIfT BioSciences is a British biotech startup developing an allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT) used to produce different types of Immunomodulatory Alpha Neutrophils (IMANs) at scale from iPSCs for a wide range of different purposes as a mono or combo.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 12.9M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to LIfT BioSciences
Name | Criteria | |
---|---|---|
![]() |
Xenothera
73%
|
|
![]() |
Amarna Therapeutics
73%
|
|
![]() |
Brenus Pharma
73%
|
|
![]() |
Kither Biotech
73%
|
|
![]() |
Relation Therapeutics
73%
|
|
![]() |
SolasCure
73%
|
|
![]() |
Bios Health
73%
|
|
![]() |
ViaNautis
73%
|
|
![]() |
Anocca
70%
|
|
![]() |
FinnAdvance
68%
|
|